The Vanilloid Agonist Resiniferatoxin for Interventional-Based Pain Control

E-ISSN： 1873-4294|11|17|2171-2179

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.11, Iss.17, 2011-09, pp. : 2171-2179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Resiniferatoxin-Induced Loss of Plasma Membrane in Vanilloid Receptor Expressing Cells

By Caudle R.M. Karai L. Mena N. Cooper B.Y. Mannes A.J. Perez F.M. Iadarola M.J. Olah Z.

Neurotoxicology, Vol. 24, Iss. 6, 2003-12 ,pp. : 895-908

Elsevier

Access to resources Recommend Favorite

Recent developments in transient receptor potential vanilloid receptor 1 agonist-based therapies

By Bley Keith R

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1445-1456

Informa Healthcare

Access to resources Recommend Favorite

Anandamide transport inhibition by the vanilloid agonist olvanil

By Beltramo M. Piomelli D.

European Journal of Pharmacology, Vol. 364, Iss. 1, 1999-01 ,pp. : 75-78

Elsevier

Access to resources Recommend Favorite

Botulinum toxin A outperforms resiniferatoxin for detrusor control

Inpharma, Vol. 1, Iss. 1449, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

A novel agonist, phorbol 12-phenylacetate 13-acetate 20-homovanillate, abolishes positive cooperativity of binding by the vanilloid receptor

By Szallasi A. Acs G. Cravotto G. Blumberg P.M. Lundberg J.M. Appendino G.

European Journal of Pharmacology, Vol. 299, Iss. 1, 1996-03 ,pp. : 221-228

Elsevier

Access to resources Recommend Favorite